Identification of an HLA-A*0201-restricted T-cell epitope derived from the prostate cancer-associated protein prostein

SYFPEITHI: database for MHC ligands and peptide motifs

1999 • 2,307 citations

Escape of Human Solid Tumors from T–Cell Recognition: Molecular Mechanisms and Functional Significance

1999 • 1,168 citations

Annual Report to the Nation on the Status of Cancer (1973 Through 1998), Featuring Cancers With Recent Increasing Trends

2001 • 758 citations

Immunotherapy of Hormone-Refractory Prostate Cancer With Antigen-Loaded Dendritic Cells

2000 • 627 citations

Genetic heterogeneity of single disseminated tumour cells in minimal residual cancer

2002 • 479 citations

Cancer vaccines based on the identification of genes encoding cancer regression antigens

1997 • 395 citations

Loss of NKX3.1 expression in human prostate cancers correlates with tumor progression.

2000 • 377 citations

A Novel Human Prostate-Specific, Androgen-Regulated Homeobox Gene (NKX3.1) That Maps to 8p21, a Region Frequently Deleted in Prostate Cancer

1997 • 363 citations

STEAP: A prostate-specific cell-surface antigen highly expressed in human prostate tumors

1999 • 321 citations

Infusion of dendritic cells pulsed with HLA-A2-specific prostate-specific membrane antigen peptides: A phase II prostate cancer vaccine trial involving patients with hormone-refractory metastatic disease

1999 • 242 citations

Molecular cloning and characterization of prostase, an androgen-regulated serine protease with prostate-restricted expression

1999 • 221 citations

Generation of survivin-specific CD8+ T effector cells by dendritic cells pulsed with protein or selected peptides.

2000 • 218 citations

Prostase/KLK-L1 is a new member of the human kallikrein gene family, is expressed in prostate and breast tissues, and is hormonally regulated.

1999 • 128 citations

Generation of Human Cytolytic T Lymphocyte Lines Directed Against Prostate-Specific Antigen (PSA) Employing a PSA Oligoepitope Peptide

1998 • 126 citations

Presentation of prostate tumor antigens by dendritic cells stimulates T-cell proliferation and cytotoxicity

1996 • 120 citations

Induction of prostate tumor-specific CD8+ cytotoxic T-lymphocytes in vitro using antigen-presenting cells pulsed with prostatic acid phosphatase peptide

1998 • 114 citations

PMEPA1, an androgen-regulated NEDD4-binding protein, exhibits cell growth inhibitory function and decreased expression during prostate cancer progression.

2003 • 113 citations

Identification and characterization of prostein, a novel prostate-specific protein.

2001 • 105 citations

PART-1: a novel human prostate-specific, androgen-regulated gene that maps to chromosome 5q12.

2000 • 96 citations

An HLA class I peptide-binding assay based on competition for binding to class I molecules on intact human B cells

1995 • 91 citations

Prostate stem cell antigen: Identification of immunogenic peptides and assessment of reactive CD8⁺ T cells in prostate cancer patients

2002 • 72 citations

INDUCTION OF TUMOR SPECIFIC CYTOTOXIC T LYMPHOCYTES IN PROSTATE CANCER USING PROSTATIC ACID PHOSPHATASE DERIVED HLA-A2402 BINDING PEPTIDE

2001 • 44 citations

Screening of HLA-A24-restricted epitope peptides from prostate-specific membrane antigen that induce specific antitumor cytotoxic T lymphocytes.

2002 • 33 citations

Expression and regulation of prostate androgen regulated transcript-1 (PART-1) and identification of differential expression in prostatic cancer

2001 • 31 citations

Target antigens for prostate cancer immunotherapy.

1999 • 27 citations

A novel human prostate-specific gene-1 (HPG-1): molecular cloning, sequencing, and its potential involvement in prostate carcinogenesis.

2003 • 23 citations

Identifying Immunotherapeutic Targets for Prostate Carcinoma through the Analysis of Gene Expression Profiles

2002 • 22 citations

Novel human prostate-specific cDNA: molecular cloning, expression, and immunobiology of the recombinant protein

2002 • 5 citations